Trial intelligence / Profile preview

Hemodynamic comparison of equipotent propofol and remifentanil combinations during anesthesia

NL-OMON40328Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Mar 2014
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of propofol and remifentanil (4 arms), sponsored by University Medical Center Groningen. Primary endpoints: Absolute hemodynamic and oxygenation measures, Change from baseline in hemodynamic and oxygenation measures and 2 more. Started Mar 2014; status: active, not recruiting.

02

Drugs

propofolremifentanil

Beyond the preview

Go deeper on NL-OMON40328.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON40328.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call